Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-521,499
Closed -$21.5M 68
2021
Q4
$21.5M Buy
521,499
+35
+0% +$1.32K 0.76% 37
2021
Q3
$18M Buy
521,464
+585
+0.1% +$20K 0.69% 41
2021
Q2
$16.5M Buy
520,879
+64,856
+14% +$2.09M 0.64% 43
2021
Q1
$14.2M Buy
+456,023
New +$13.7M 0.55% 43
2015
Q1
Sell
-153,362
Closed -$4.06M 78
2014
Q4
$4.06M Sell
153,362
-2,023,906
-93% -$51.9M 0.08% 69
2014
Q3
$52.9M Buy
2,177,268
+251
+0% +$5.88K 1.09% 28
2014
Q2
$56.6M Sell
2,177,017
-1,146,588
-34% -$29.2M 1.06% 30
2014
Q1
$79.6M Sell
3,323,605
-603
-0% -$12.7K 1.55% 22
2013
Q4
$64.9M Buy
3,324,208
+141,386
+4% +$2.85M 1.29% 28
2013
Q3
$67.3M Buy
3,182,822
+345
+0% +$7.55K 1.42% 26
2013
Q2
$70.1M Buy
+3,182,477
New +$77.2M 1.52% 26

Other funds holding EXC

Donald Smith & Co's EXC Position: Q1 2022 in Review

Donald Smith & Co sold out of Exelon (EXC) in Q1 2022, closing a stake of 521,499 shares — an estimated $21.5M sold.

Donald Smith & Co first reported a position in EXC in Q2 2013 and held it in 11 quarters. The position peaked at $79.6M in Q1 2014. 1,025 funds tracked by Wall St. Rank hold EXC as of Q1 2022.

  • Donald Smith & Co reported no remaining Exelon position as of Q1 2022 after selling out during the quarter.
  • Donald Smith & Co sold 521,499 Exelon shares in Q1 2022, an estimated $21.5M.
  • Donald Smith & Co first reported a position in Exelon in Q2 2013 and held it in 11 quarters.
  • Donald Smith & Co's Exelon position peaked at $79.6M in Q1 2014.
  • 1,025 funds tracked by Wall St. Rank held Exelon as of Q1 2022.

Based on Donald Smith & Co's 13F filing for Q1 2022, filed 9 May 2022.